Daniel Marshall
Senior Manager of Communications and Ownership
Replay available
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.

Senior Manager of Communications and Ownership
Co-founder and CEO
Chief Financial Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Ginkgo Bioworks Holdings, Inc..
WEBVTT 00:00:01.160 -- 00:00:06.520 Good evening. I'm Daniel Marshall, Senior Manager of Communications and Ownership. 00:00:06.520 -- 00:00:12.100 I'm joined by Jason Kelly, our co-founder and CEO, and our new CFO, Steve Cohen. 00:00:12.100 -- 00:00:16.860 Thanks as always for joining us. We're looking forward to updating you on our progress. 00:00:16.860 -- 00:00:21.200 As a reminder, during the presentation today, we'll be making forward-looking statements 00:00:21.200 -- 00:00:26.080 which involve risks and uncertainties. Please refer to our filings with the SEC to learn 00:00:26.080 -- 00:00:31.340 more about these risks and uncertainties, including our most recent 10K. 00:00:31.500 -- 00:00:35.900 Today, in addition to updating you on the quarter results, we're going to provide updates 00:00:35.900 -- 00:00:40.440 on our path towards adjusted EBITDA breakeven and dive deeper into the new deals and 00:00:40.440 -- 00:00:44.800 launches in Ginkgo's tools businesses, which continue to establish themselves as critical 00:00:44.800 -- 00:00:47.560 tools in AI-powered bioengineering. 00:00:47.560 -- 00:00:52.640 As usual, we'll end with a Q&A session and I'll take questions from journalists, investors, 00:00:52.640 -- 00:00:58.000 and the public. You can submit those questions to us in advance via X, hashtag, 00:00:58.000 -- 00:01:02.580 GinkgoResults, or email investors at ginkgobioworks.com. 00:01:02.760 -- 00:01:04.340 All right, over to you, Jason. 00:01:04.340 -- 00:01:07.860 All right. Thanks, Daniel. We always start with our mission here at Ginkgo, which is 00:01:07.860 -- 00:01:11.800 to make biology easier to engineer. Our objectives are very similar to what you've heard 00:01:11.800 -- 00:01:16.940 from me over the last few earnings calls. We're trying to r...